Could a common antibiotic help fight MS by changing gut bacteria?
NCT ID NCT05539729
First seen Jun 26, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This study is testing whether the antibiotic vancomycin can change the gut bacteria and immune system of people with newly diagnosed multiple sclerosis (MS). The researchers will give vancomycin or a placebo to 12 people and measure changes in gut bacteria, blood markers, and brain scans. The goal is to understand how gut bacteria might affect MS, not to find a treatment yet.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- vancomycin
- What this could lead to
- If it works, this could point toward a way to treat MS by targeting gut bacteria.
- What could go wrong
- This is a very small, early-phase study with only 12 people. It is designed to test a theory, not to prove a treatment works.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Corinne Goldsmith Dickinson Center for Multiple Sclerosis at Mount Sinai
RECRUITINGNew York, New York, 10029, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can we decode the different types of pain in multiple sclerosis?
- Can a blood pressure pill slow MS disability?
- Hidden MS progression: can brain scans and blood tests predict it?
- Can Brain-Training apps fix sleep in MS?
- Can an Iron-Based dye reveal hidden inflammation in progressive MS?
- Strumming for the brain: could ukulele lessons sharpen minds in MS?